tiprankstipranks
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
Hong Kong Market
3692
Hansoh Pharmaceutical Group Company Limited
RESEARCH TOOLSreports
Want to see HK:3692 full AI Analyst Report?

Hansoh Pharmaceutical Group Company Limited (3692) Ratios

8 Followers

Hansoh Pharmaceutical Group Company Limited Ratios

HK:3692's free cash flow for Q4 2025 was ¥0.89. For the 2025 fiscal year, HK:3692's free cash flow was decreased by ¥ and operating cash flow was ¥0.30. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 8.09 8.09 10.18 4.21 9.86
Quick Ratio
 7.95 7.95 9.94 4.12 9.69
Cash Ratio
 0.78 0.78 8.39 3.27 6.72
Solvency Ratio
 1.31 1.30 1.59 0.50 0.40
Operating Cash Flow Ratio
 0.90 1.53 1.43 0.45 1.05
Short-Term Operating Cash Flow Coverage
 97.64 166.37 94.49 0.74 0.00
Net Current Asset Value
¥ 31.03B¥ 31.03B¥ 24.46B¥ 21.64B¥ 18.48B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 0.13 0.15
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 0.17 0.19
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.14 0.16
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 <0.01 0.16
Financial Leverage Ratio
 1.13 1.13 1.10 1.28 1.32
Debt Service Coverage Ratio
 113.69 109.26 74.94 0.87 44.15
Interest Coverage Ratio
 3.60K 1.71K 602.65 42.58 45.94
Debt to Market Cap
 <0.01 <0.01 <0.01 0.05 0.06
Interest Debt Per Share
 0.02 0.02 0.02 0.70 0.75
Net Debt to EBITDA
 -0.57 -0.57 -5.26 -4.32 -4.52
Profitability Margins
Gross Profit Margin
89.89%89.89%90.98%89.80%90.73%
EBIT Margin
35.94%35.94%31.83%37.93%27.79%
EBITDA Margin
38.40%38.37%34.89%41.56%31.25%
Operating Profit Margin
36.04%36.04%32.88%28.10%28.47%
Pretax Profit Margin
43.59%43.59%41.48%37.27%31.43%
Net Profit Margin
36.97%36.97%35.66%32.44%27.54%
Continuous Operations Profit Margin
36.97%36.97%35.66%32.44%27.54%
Net Income Per EBT
84.81%84.81%85.97%87.03%87.63%
EBT Per EBIT
120.96%120.96%126.15%132.64%110.38%
Return on Assets (ROA)
13.92%13.92%13.81%9.92%8.61%
Return on Equity (ROE)
16.71%15.70%15.24%12.71%11.41%
Return on Capital Employed (ROCE)
15.25%15.25%13.92%10.85%9.76%
Return on Invested Capital (ROIC)
12.91%12.91%11.94%8.13%8.54%
Return on Tangible Assets
14.05%14.05%13.92%9.97%8.62%
Earnings Yield
3.13%2.87%4.54%3.66%3.33%
Efficiency Ratios
Receivables Turnover
 4.91 4.91 3.84 3.13 2.62
Payables Turnover
 4.54 4.54 5.07 6.29 3.91
Inventory Turnover
 2.49 2.49 1.70 1.79 1.94
Fixed Asset Turnover
 4.68 4.68 3.78 3.08 2.69
Asset Turnover
 0.38 0.38 0.39 0.31 0.31
Working Capital Turnover Ratio
 0.51 0.54 0.52 0.45 0.43
Cash Conversion Cycle
 140.37 140.37 238.14 262.49 233.83
Days of Sales Outstanding
 74.36 74.36 95.05 116.61 139.21
Days of Inventory Outstanding
 146.36 146.36 215.03 203.87 187.87
Days of Payables Outstanding
 80.35 80.35 71.93 57.98 93.24
Operating Cycle
 220.72 220.72 310.08 320.48 327.08
Cash Flow Ratios
Operating Cash Flow Per Share
 0.66 1.13 0.65 0.50 0.46
Free Cash Flow Per Share
 0.63 1.04 0.61 0.46 0.42
CapEx Per Share
 0.03 0.08 0.04 0.04 0.05
Free Cash Flow to Operating Cash Flow
 0.95 0.93 0.94 0.93 0.90
Dividend Paid and CapEx Coverage Ratio
 1.80 2.69 1.86 3.58 2.78
Capital Expenditure Coverage Ratio
 21.58 13.77 17.40 14.19 10.05
Operating Cash Flow Coverage Ratio
 37.61 64.09 32.76 0.72 0.63
Operating Cash Flow to Sales Ratio
 0.26 0.45 0.32 0.31 0.29
Free Cash Flow Yield
2.10%3.22%3.78%3.23%3.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 31.99 34.88 22.01 27.33 30.00
Price-to-Sales (P/S) Ratio
 11.94 12.90 7.85 8.86 8.26
Price-to-Book (P/B) Ratio
 5.02 5.48 3.36 3.47 3.42
Price-to-Free Cash Flow (P/FCF) Ratio
 47.58 31.01 26.44 30.92 31.40
Price-to-Operating Cash Flow Ratio
 44.94 28.76 24.92 28.74 28.28
Price-to-Earnings Growth (PEG) Ratio
 1.25 1.36 0.46 2.00 -6.90
Price-to-Fair Value
 5.02 5.48 3.36 3.47 3.42
Enterprise Value Multiple
 30.52 33.04 17.24 17.01 21.93
Enterprise Value
 176.13B 190.49B 73.74B 71.43B 64.28B
EV to EBITDA
 30.52 33.04 17.24 17.01 21.93
EV to Sales
 11.72 12.68 6.01 7.07 6.85
EV to Free Cash Flow
 46.70 30.48 20.26 24.66 26.04
EV to Operating Cash Flow
 44.54 28.27 19.09 22.92 23.45
Tangible Book Value Per Share
 5.83 5.86 4.79 4.08 3.82
Shareholders’ Equity Per Share
 5.89 5.92 4.84 4.11 3.83
Tax and Other Ratios
Effective Tax Rate
 0.15 0.15 0.14 0.13 0.12
Revenue Per Share
 2.50 2.51 2.07 1.61 1.59
Net Income Per Share
 0.93 0.93 0.74 0.52 0.44
Tax Burden
 0.85 0.85 0.86 0.87 0.88
Interest Burden
 1.21 1.21 1.30 0.98 1.13
Research & Development to Revenue
 0.22 0.22 0.22 0.21 0.18
SG&A to Revenue
 0.32 0.32 0.37 0.07 0.06
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.01 0.02 0.02
Income Quality
 0.60 1.03 0.88 0.95 1.06
Currency in CNY